Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rapid Dose Therapeutics Corp C.DOSE

Alternate Symbol(s):  RDTCF

Cannabis
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. The Company provides disruptive drug delivery technologies designed to improve patient outcomes. The Company’s flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into... see more

Recent & Breaking News (CSE:DOSE)

Rapid Dose Therapeutics Provides Shareholder Update Regarding Vaccine Collaboration Agreement with Oakland Health Limited in the United Kingdom

Business Wire May 12, 2022

Rapid Dose Therapeutics and Skycare Compounding Labs to Provide Patients with a Novel Oral Delivery Option for Pharmaceutical Products

Business Wire April 26, 2022

RD Therapeutics and Rapid Dose Therapeutics Participate in the CEPI Global Pandemic Preparedness Summit and Support the #100DaysMission

Business Wire March 8, 2022

Rapid Dose Therapeutics Announces Management Change

Business Wire February 10, 2022

Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board

Business Wire January 5, 2022

Rapid Dose (CSE:DOSE) and McMaster University receive grant for COVID-19 vaccine research

Julia Kennedy  December 23, 2021

Rapid Dose and McMaster University's COVID-19 vaccine study receives NSERC R&D grant

Stockhouse Editorial December 23, 2021

Rapid Dose Therapeutics and McMaster University's COVID-19 Vaccine Study Receives NSERC Research and Development Grant

Business Wire December 22, 2021

Rapid Dose Therapeutics Strengthens Leadership Team with Addition of Rodney Butt & Appoints New Advisory Board Member

Business Wire December 15, 2021

Rapid Dose signs product supply agreement with Oakland Health in the UK & EU

Stockhouse Editorial December 14, 2021

Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United Kingdom

Business Wire Canada December 9, 2021

Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures for Business Development Advisory Services with First Nations Enterprises

Business Wire November 30, 2021

Rapid Dose Therapeutics Completes Milestone One Million QuickStrip(TM) Units Shipped to a Single Company

Business Wire November 24, 2021

Rapid Dose Therapeutics Completes Significant Shipment of QuickStrip(TM) Products to Thrive Cannabis

Business Wire November 9, 2021

Lifeist Wellness Reports Continuing Improved Trends in Q3 2021

GlobeNewswire October 29, 2021

A Made-in-Canada Solution to the Global COVID Crisis

Stockhouse Editorial October 21, 2021

Rapid Dose Therapeutics Receives Cannabis Sales License from Health Canada

Business Wire October 1, 2021

Rapid Dose Therapeutics Welcomed Premier Doug Ford to Tour Burlington Facility

Business Wire September 28, 2021

 Rapid Dose Therapeutics and McMaster University Provide COVID-19 Vaccine Research Update Including Significant Achievement of Milestones

Business Wire September 15, 2021